A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare ‘poor prognosis’ myeloid malignancies
Authors:
Open Access
- 20 April 2006
- journal article
- letter
- Published by Springer Nature in Leukemia
- Vol. 20 (7) , 1295-1297
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Age and acute myeloid leukemiaBlood, 2006
- DEK-CAN molecular monitoring of myeloid malignancies could aid therapeutic stratificationLeukemia, 2005
- Acute Myeloid Leukemia With t(6;9)(p23;q34) Is Associated With Dysplasia and a High Frequency offlt3Gene MutationsAmerican Journal of Clinical Pathology, 2004
- Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemiaBritish Journal of Haematology, 2004
- Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosisBlood, 2002
- Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group studyBlood, 2000
- The World Health Organization Classification of Hematological Malignancies Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997Laboratory Investigation, 2000
- Acute Myeloid Leukemia With t(6;9) (p23;q34):Association With Myelodysplasia, Basophilia, and Initial CD34 Negative ImmunophenotypeAmerican Journal of Clinical Pathology, 1997